Meeting of the Chronic Fatigue Syndrome Advisory Committee, 25275-25276 [2013-10083]

Download as PDF Federal Register / Vol. 78, No. 83 / Tuesday, April 30, 2013 / Notices included in an April 1–June 30, 2012, quarterly report to NIAID. • In Liquid Logic laboratory documents, the Respondent falsified the graphs of RT–PCR results of the Escherichia coli bacteriophage MS2, an internal control, viral loads for three (3) clinical samples, when the results were actually from prior experiments of two (2) controls and one (1) unrelated clinical sample. The Respondent falsified the MS2 graphs in an effort to conceal that RT–PCR experiments of the clinical samples had not been performed. Mr. Poore has entered into a Voluntary Settlement Agreement and has voluntarily agreed for a period of three (3) years, beginning on April 1, 2013: (1) To have his research supervised; Respondent agreed that prior to the submission of an application for U.S. Public Health Service (PHS) support for a research project on which his participation is proposed and prior to his participation in any capacity on PHS-supported research, Respondent shall ensure that a plan for supervision of his duties is submitted to ORI for approval; the supervision plan must be designed to ensure the scientific integrity of his research contribution; he agreed that he shall not participate in any PHS-supported research until such a supervision plan is submitted to and approved by ORI; Respondent agreed to maintain responsibility for compliance with the agreed upon supervision plan; and (2) To exclude himself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8200. David E. Wright, Director, Office of Research Integrity. [FR Doc. 2013–10085 Filed 4–29–13; 8:45 am] BILLING CODE 4150–31–P pmangrum on DSK3VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Chronic Fatigue Syndrome Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: VerDate Mar<15>2010 13:22 Apr 29, 2013 Jkt 229001 SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a meeting. The meeting will be open to the public. DATES: The meeting will be held on Wednesday, May 22, 2013, and Thursday, May 23, 2013, from 9:00 a.m. until 5:00 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building; 200 Independence Avenue SW., Room 800; Washington, DC 20201. For a map and directions to the Hubert H. Humphrey building, please visit http://www.hhs.gov/about/ hhhmap.html. FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, M.D., Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee, Department of Health and Human Services, 200 Independence Avenue SW., Room 712E, Washington, DC 20201. Any questions about meeting registration or public comment sign-up should be directed to CFSACMay2013@seamon corporation.com. Please direct other inquiries to cfsac@hhs.gov. SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002, to advise, consult with, and make recommendations to the Secretary, through the Assistant Secretary for Health, on a broad range of topics including: (1) The current state of knowledge and research and the relevant gaps in knowledge and research about the epidemiology, etiologies, biomarkers, and risk factors relating to CFS, and identifying potential opportunities in these areas; (2) impact and implications of current and proposed diagnosis and treatment methods for CFS; (3) development and implementation of programs to inform the public, health care professionals, and the biomedical academic and research communities about CFS advances; and (4) partnering to improve the quality of life of CFS patients. The agenda for this meeting is being developed and will be posted on the CFSAC Web site, http://www.hhs.gov/ advcomcfs when finalized. The meeting will be live-video streamed at www.HHS.gov/Live and archived through the CFSAC Web site: www.hhs.gov/advocomcfs. Listeningonly audio via telephone will be available on both days. Call-in information will be posted on the CFSAC Web site. Individuals who plan to attend should register at the following link by May 17, PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 25275 2013: http://www.blsmeetings.net/ CFSACMay2013. Attendance by visitors who are not U.S. citizens is welcome, but prior approval is required by sending a request to CFSACMay2013@seamon corporation.com before May 8, 2013. Members of the media will also need to register. All attendees will be required to show government-issued picture identification (state or federal) for entry into a federal building. Attendees will receive a wrist band that must be worn the entire time. Security requires all non-federal employees to be escorted the entire time they are in the building. Upon leaving the building for any reason, all persons will be required to follow the security steps mentioned above and receive a new wrist band. Members of the public will have the opportunity to provide public comment at the meeting or via telephone. International calls cannot be accommodated. You are no longer required to submit a written copy of your testimony as in past years unless you wish to have it included in the public record. Individuals wishing to submit public comment for public record must send an electronic copy of their testimony in advance to: CFSACMay2013@seamon corporation.com by Wednesday, May 15, 2013. A separate sign-up process for requesting time for public comment must be completed by Wednesday, May 15, 2013 at the following link: http:// www.blsmeetings.net/CFSACPublic CommentMay2013. An email to acknowledge receipt of the request for public comment will be sent from this email address. The document for public record must not exceed 5 single-spaced, typed pages, using a 12-point typeface; it is preferred that the document be prepared in the MSWord format. Please note that PDF files, handwritten notes, charts, and photographs that are submitted for distribution to the Committee will not be posted on the CFSAC Web site. However, this material will be made available for the public to view on site during the dates that the meeting is being conducted. Individuals who wish to view this material after the meeting should contact the CFSAC DFO, whose contact information is included in this Federal Register notice. Requests to participate in the public comment and provide written testimony will not be accepted through the CFSAC mailbox. Also, the CFSAC mailbox will not respond to questions about specific public comment requests. These requests and/or inquiries should be directed to CFSACMay2013@seamon corporation.com. E:\FR\FM\30APN1.SGM 30APN1 25276 Federal Register / Vol. 78, No. 83 / Tuesday, April 30, 2013 / Notices Only testimony submitted for public record and received in advance of the meeting are part of the official meeting record and will be posted to the CFSAC Web site. Materials submitted should not include sensitive personal information, such as social security number, birthdates, driver’s license number, state identification or foreign country equivalent, passport number, financial account number, or credit or debit card number. If you wish to remain anonymous the document must specify this. We will confirm your time for public comment via email by May 17, 2013. Each speaker will be limited to five minutes per speaker; no exceptions will be made. We will give priority to individuals who have not provided public comment within the previous year. Persons who wish to distribute printed materials to CFSAC members should submit one copy for approval to the Designated Federal Officer at cfsac@hhs.gov, prior to Friday, May 17, 2013. Dated: April 15, 2013. Nancy C. Lee, Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee. [FR Doc. 2013–10083 Filed 4–29–13; 8:45 am] BILLING CODE 4150–42–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of Minority Health, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of a virtual public meeting. pmangrum on DSK3VPTVN1PROD with NOTICES AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that a meeting of the Advisory Committee on Minority Health (ACMH) will be held virtually. This virtual meeting will take place via webinar and audio video conferencing technology. This meeting will be open to the public. Preregistration is required for both virtual public participation and comment. Any individual who wishes to participate in the virtual public meeting and/or in the public comment session should preregister at the following email address: acmh@osophs.dhhs.gov. VerDate Mar<15>2010 13:22 Apr 29, 2013 Jkt 229001 The meeting will be held virtually on Thursday, May 16, 2013, from 10:00 a.m. to 1:00 p.m. (EST). ADDRESSES: The meeting will be conducted virtually only. FOR FURTHER INFORMATION CONTACT: Ms. Monica A. Baltimore, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240– 453–2882; Fax: 240–453–2883. SUPPLEMENTARY INFORMATION: In accordance with Public Law 105–392, the ACMH was established to provide advice to the Deputy Assistant Secretary for Minority Health in improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the Office of Minority Health. Topics to be discussed during this meeting will include patient protections, consumer assistance, and the Affordable Care Act. The Committee will also discuss strategies to improve the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities. To participate in this meeting, please follow the instructions below: (1) Participants are asked to dial in 15 minutes prior to the scheduled start time. (2) For audio, participant Dial-in Numbers: U.S. Toll Free: 800–875–3456 Canadian Toll Free: 800–648–0973 International Toll Free: 302–607–2001 Verbal Passcode (to be given to the operator): VS11535 This webinar will be limited to 125 participants. The Office of Minority Health will make every effort to accommodate persons with special needs. Individuals who have special needs for which special accommodations may be required should contact Professional and Scientific Associates at (703) 234–1700 and reference this meeting. Requests for special accommodations should be made at least ten (10) business days prior to the meeting. Webinar Instructions: Go to http://lotuslive.readyshow.com. Before logging in, click on ‘‘Check your browser compatibility’’ at the bottom. Participants will log in under the ‘‘Join A Conference’’ section. The Participant Passcode is 53385094. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to two minutes per speaker during the time allotted. Individuals who would like to submit written statements should mail or fax their DATES: PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 comments to the Office of Minority Health at least seven (7) business days prior to the meeting. Public Comment: To participate during the public comment session please follow instructions below: Press *1 to make a comment. Press # to remove the comment from the comment queue. Any members of the public who wish to have printed material distributed to ACMH members should submit their materials to the Executive Director, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business Tuesday, May 7, 2013. Dated: April 17, 2013. Monica A. Baltimore, Executive Director, Advisory Committee on Minority Health, Office of Minority Health, U.S. Department of Health and Human Services. [FR Doc. 2013–10084 Filed 4–29–13; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Opportunity and Procedure To Submit Nominations for Nutrients of Interest for Dietary Reference Intake Reviews Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion. AGENCY: Authority: 42 U.S.C. 300u(a). ACTION: Notice. SUMMARY: The Dietary Reference Intake (DRI) Subcommittee, an entity within the federal Interagency Committee on Human Nutrition Research, has developed procedures jointly with its Canadian counterpart to allow interested parties to nominate nutrients for consideration for DRI review. This notice will serve to announce the opportunity to submit such information to the DRI Subcommittee as it considers updates for nutrients and food components that have previously been considered by Institute of Medicine DRI committees. DATES: The DRI Subcommittee will accept nominations for consideration beginning April 29, 2013 through 11:59 p.m. EDT on July 31, 2013. ADDRESSES: Nominations may be submitted by email in the required format and to the email addresses specified in the Dietary Reference Intakes page on the Web site: www.health.gov/DRI. E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 78, Number 83 (Tuesday, April 30, 2013)]
[Notices]
[Pages 25275-25276]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-10083]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a 
meeting. The meeting will be open to the public.

DATES: The meeting will be held on Wednesday, May 22, 2013, and 
Thursday, May 23, 2013, from 9:00 a.m. until 5:00 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building; 200 Independence Avenue SW., Room 800; Washington, DC 20201. 
For a map and directions to the Hubert H. Humphrey building, please 
visit http://www.hhs.gov/about/hhhmap.html.

FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, M.D., Designated Federal 
Officer, Chronic Fatigue Syndrome Advisory Committee, Department of 
Health and Human Services, 200 Independence Avenue SW., Room 712E, 
Washington, DC 20201. Any questions about meeting registration or 
public comment sign-up should be directed to 
CFSACMay2013@seamoncorporation.com. Please direct other inquiries to 
cfsac@hhs.gov.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002, 
to advise, consult with, and make recommendations to the Secretary, 
through the Assistant Secretary for Health, on a broad range of topics 
including: (1) The current state of knowledge and research and the 
relevant gaps in knowledge and research about the epidemiology, 
etiologies, biomarkers, and risk factors relating to CFS, and 
identifying potential opportunities in these areas; (2) impact and 
implications of current and proposed diagnosis and treatment methods 
for CFS; (3) development and implementation of programs to inform the 
public, health care professionals, and the biomedical academic and 
research communities about CFS advances; and (4) partnering to improve 
the quality of life of CFS patients.
    The agenda for this meeting is being developed and will be posted 
on the CFSAC Web site, http://www.hhs.gov/advcomcfs when finalized. The 
meeting will be live-video streamed at www.HHS.gov/Live and archived 
through the CFSAC Web site: www.hhs.gov/advocomcfs. Listening-only 
audio via telephone will be available on both days. Call-in information 
will be posted on the CFSAC Web site.
    Individuals who plan to attend should register at the following 
link by May 17, 2013: http://www.blsmeetings.net/CFSACMay2013. 
Attendance by visitors who are not U.S. citizens is welcome, but prior 
approval is required by sending a request to 
CFSACMay2013@seamoncorporation.com before May 8, 2013. Members of the 
media will also need to register. All attendees will be required to 
show government-issued picture identification (state or federal) for 
entry into a federal building. Attendees will receive a wrist band that 
must be worn the entire time. Security requires all non-federal 
employees to be escorted the entire time they are in the building. Upon 
leaving the building for any reason, all persons will be required to 
follow the security steps mentioned above and receive a new wrist band.
    Members of the public will have the opportunity to provide public 
comment at the meeting or via telephone. International calls cannot be 
accommodated. You are no longer required to submit a written copy of 
your testimony as in past years unless you wish to have it included in 
the public record. Individuals wishing to submit public comment for 
public record must send an electronic copy of their testimony in 
advance to: CFSACMay2013@seamoncorporation.com by Wednesday, May 15, 
2013. A separate sign-up process for requesting time for public comment 
must be completed by Wednesday, May 15, 2013 at the following link: 
http://www.blsmeetings.net/CFSACPublicCommentMay2013. An email to 
acknowledge receipt of the request for public comment will be sent from 
this email address. The document for public record must not exceed 5 
single-spaced, typed pages, using a 12-point typeface; it is preferred 
that the document be prepared in the MSWord format. Please note that 
PDF files, handwritten notes, charts, and photographs that are 
submitted for distribution to the Committee will not be posted on the 
CFSAC Web site. However, this material will be made available for the 
public to view on site during the dates that the meeting is being 
conducted. Individuals who wish to view this material after the meeting 
should contact the CFSAC DFO, whose contact information is included in 
this Federal Register notice. Requests to participate in the public 
comment and provide written testimony will not be accepted through the 
CFSAC mailbox. Also, the CFSAC mailbox will not respond to questions 
about specific public comment requests. These requests and/or inquiries 
should be directed to CFSACMay2013@seamoncorporation.com.

[[Page 25276]]

    Only testimony submitted for public record and received in advance 
of the meeting are part of the official meeting record and will be 
posted to the CFSAC Web site. Materials submitted should not include 
sensitive personal information, such as social security number, 
birthdates, driver's license number, state identification or foreign 
country equivalent, passport number, financial account number, or 
credit or debit card number. If you wish to remain anonymous the 
document must specify this.
    We will confirm your time for public comment via email by May 17, 
2013. Each speaker will be limited to five minutes per speaker; no 
exceptions will be made. We will give priority to individuals who have 
not provided public comment within the previous year.
    Persons who wish to distribute printed materials to CFSAC members 
should submit one copy for approval to the Designated Federal Officer 
at cfsac@hhs.gov, prior to Friday, May 17, 2013.

    Dated: April 15, 2013.
Nancy C. Lee,
Designated Federal Officer, Chronic Fatigue Syndrome Advisory 
Committee.
[FR Doc. 2013-10083 Filed 4-29-13; 8:45 am]
BILLING CODE 4150-42-P